ALIGNMENT HEALTHCARE, INC. Selling, General and Administrative Expense
ALIGNMENT HEALTHCARE, INC. (ALHC) reported Selling, General and Administrative Expense of $131.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-30
- ALIGNMENT HEALTHCARE, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $131.00M, a 26.21% increase year-over-year.
- ALIGNMENT HEALTHCARE, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $121.14M, a 16.67% increase year-over-year.
- ALIGNMENT HEALTHCARE, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $125.76M, a 23.14% increase year-over-year.
- ALIGNMENT HEALTHCARE, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $110.02M, a 21.07% increase year-over-year.
- ALIGNMENT HEALTHCARE, INC. selling, general and administrative expense for fiscal 2025 was $443.41M, a 19.40% increase from fiscal 2024.
- ALIGNMENT HEALTHCARE, INC. selling, general and administrative expense for fiscal 2024 was $371.37M, a 20.80% increase from fiscal 2023.
- ALIGNMENT HEALTHCARE, INC. selling, general and administrative expense for fiscal 2023 was $307.43M, a 3.99% increase from fiscal 2022.
- ALIGNMENT HEALTHCARE, INC. selling, general and administrative expense for fiscal 2022 was $295.65M, a 1.60% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $131.00M 10-Q · filed 2026-07-30 | $252.14M 10-Q · filed 2026-07-30 | $377.90M derived: sum of 3 quarters · filed 2026-07-30 | $487.92M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $121.14M 10-Q · filed 2026-04-30 | $246.90M derived: sum of 2 quarters · filed 2026-04-30 | $356.92M derived: sum of 3 quarters · filed 2026-04-30 | $460.71M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $125.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $235.78M derived: sum of 2 quarters · filed 2026-02-27 | $339.58M derived: sum of 3 quarters · filed 2026-07-30 | $443.41M 10-K · filed 2026-02-27 |
| 2025-09-30 | $110.02M 10-Q · filed 2025-10-30 | $213.81M derived: sum of 2 quarters · filed 2026-07-30 | $317.64M 10-Q · filed 2025-10-30 | $419.77M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $103.80M 10-Q · filed 2026-07-30 | $207.63M 10-Q · filed 2026-07-30 | $309.76M derived: sum of 3 quarters · filed 2026-07-30 | $400.63M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $103.83M 10-Q · filed 2026-04-30 | $205.96M derived: sum of 2 quarters · filed 2026-04-30 | $296.83M derived: sum of 3 quarters · filed 2026-04-30 | $384.69M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $102.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $193.00M derived: sum of 2 quarters · filed 2026-02-27 | $280.86M derived: sum of 3 quarters · filed 2026-02-27 | $371.37M 10-K · filed 2026-02-27 |
| 2024-09-30 | $90.87M 10-Q · filed 2025-10-30 | $178.73M derived: sum of 2 quarters · filed 2025-10-30 | $269.25M 10-Q · filed 2025-10-30 | $352.98M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $87.86M 10-Q · filed 2025-07-30 | $178.38M 10-Q · filed 2025-07-30 | $262.11M derived: sum of 3 quarters · filed 2026-02-27 | $345.20M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $90.51M 10-Q · filed 2025-05-01 | $174.25M derived: sum of 2 quarters · filed 2026-02-27 | $257.34M derived: sum of 3 quarters · filed 2026-02-27 | $327.54M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $83.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $166.83M derived: sum of 2 quarters · filed 2026-02-27 | $237.03M derived: sum of 3 quarters · filed 2026-02-27 | $307.43M 10-K · filed 2026-02-27 |
| 2023-09-30 | $83.09M 10-Q · filed 2024-10-29 | $153.29M derived: sum of 2 quarters · filed 2024-10-29 | $223.70M 10-Q · filed 2024-10-29 | $306.92M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $70.20M 10-Q · filed 2024-08-01 | $140.61M 10-Q · filed 2024-08-01 | $223.84M derived: sum of 3 quarters · filed 2025-02-27 | $300.29M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $70.41M 10-Q · filed 2024-05-02 | $153.64M derived: sum of 2 quarters · filed 2025-02-27 | $230.09M derived: sum of 3 quarters · filed 2025-02-27 | $291.76M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $83.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $159.68M derived: sum of 2 quarters · filed 2025-02-27 | $221.35M derived: sum of 3 quarters · filed 2025-02-27 | $295.65M 10-K · filed 2025-02-27 |
| 2022-09-30 | $76.45M 10-Q · filed 2023-11-02 | $138.13M derived: sum of 2 quarters · filed 2023-11-02 | $212.42M 10-Q · filed 2023-11-02 | $290.50M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $61.67M 10-Q · filed 2023-08-03 | $135.97M 10-Q · filed 2023-08-03 | $214.05M derived: sum of 3 quarters · filed 2024-02-27 | $290.89M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $74.29M 10-Q · filed 2023-05-04 | $152.37M derived: sum of 2 quarters · filed 2024-02-27 | $229.22M derived: sum of 3 quarters · filed 2024-02-27 | $300.37M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $78.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $154.93M derived: sum of 2 quarters · filed 2024-02-27 | $226.08M derived: sum of 3 quarters · filed 2024-02-27 | $290.99M 10-K · filed 2024-02-27 |
| 2021-09-30 | $76.85M 10-Q · filed 2022-11-03 | $148.00M derived: sum of 2 quarters · filed 2022-11-03 | $212.91M 10-Q · filed 2022-11-03 | $264.03M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $71.15M 10-Q · filed 2022-08-04 | $136.06M 10-Q · filed 2022-08-04 | $187.18M derived: sum of 3 quarters · filed 2023-02-28 | $225.98M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $64.91M 10-Q · filed 2022-05-05 | $116.03M derived: sum of 2 quarters · filed 2023-02-28 | $154.83M derived: sum of 3 quarters · filed 2023-02-28 | $188.53M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $51.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $89.91M derived: sum of 2 quarters · filed 2023-02-28 | $123.61M derived: sum of 3 quarters · filed 2023-02-28 | $156.40M 10-K · filed 2023-02-28 |
| 2020-09-30 | $38.79M 10-Q · filed 2021-11-04 | $72.49M derived: sum of 2 quarters · filed 2021-11-04 | $105.28M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $33.70M 10-Q · filed 2021-08-09 | $66.48M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $32.79M 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | $110.13M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |